PM Modi Likely To Visit US For G20 Summit In Florida, Bilateral Ties With Canada

Markets Open Flat, S&P Ups GDP Target & SC Flags Medicine PricingIndian equity markets opened on a steady note above 23,400 levels, supported by gains in financial and banking stocks alongside broad-based sector participation. S&P raised India's FY27 GDP growth forecast by 40 basis points to 7 per cent, citing robust industrial activity, strong exports, and government spending, while projecting a repo rate hike by the Reserve Bank of India. Meanwhile, the Supreme Court raised serious concerns over the significant gap between the price to retailer (PTR) and the maximum retail price (MRP) of essential and life-saving medicines, questioning why more drugs are not covered under the drug price control order. Pharma companies, represented in court, cited research and development alongside marketing expenses for the variance in pricing. Additionally, global geopolitical developments remained in focus as Donald Trump highlighted sweeping tariff authorities and expressed support for the India-Middle East-Europe Economic Corridor.